60-DAY MONEY-BACK GUARANTEE

Protein on a GLP-1 medication: how much you need and how to protect muscle

What four obesity and nutrition societies recommend, how much of the weight lost on these drugs is lean mass, and how to get protein in when you're not hungry.

Last reviewed September 16, 2026. Written by Understory Nutrition from the studies listed under Sources and not reviewed by a clinician. Understory sells a supplement for adults taking GLP-1 medications, but not a protein product.

How much protein do you need on a GLP-1?

No single protein target is agreed for people on GLP-1 medications. A 2025 joint advisory from four obesity and nutrition societies notes that 1.2 to 1.6 g of protein per kilogram of body weight has been proposed during active weight loss, and offers an absolute target of 80 to 120 g a day as a simpler option. It advises against staying at 2 g per kilogram or more for long [1].

Key numbers

  • A 2025 advisory from four medical and nutrition societies offers an absolute target of 80 to 120 g of protein a day as one practical option on a GLP-1 [1].
  • In the STEP 1 trial of semaglutide, 38% of the weight lost was lean body mass, which the advisory estimates means about 20% of the weight lost was muscle [1].
  • Only 43% of GLP-1 users in a food-record study reached 1.2 g of protein per kilogram of adjusted body weight [2].
  • The advisory says more protein alone is likely not enough to preserve muscle without structured strength training [1].

Why is it hard to eat enough protein on a GLP-1?

GLP-1 medications sharply cut how much people eat. The 2025 advisory reports calorie intake 16% to 39% lower than with placebo, and says reduced appetite and taste aversions can make adequate protein difficult. It adds that intakes below 1,200 kcal a day for women or 1,800 for men raise the risk of falling short on essential vitamins and minerals [1].

In a food-record study of 69 GLP-1 users, only 43% reached 1.2 g of protein per kilogram of adjusted body weight, 10% reached 1.6 g and 5% reached 2.0 g. Average intake was 77.3 g a day [2].

How much muscle do people lose on GLP-1 medications?

In the STEP 1 trial of semaglutide, 5.3 kg of the average 13.6 kg lost, about 38%, was lean body mass rather than fat. Because muscle is roughly half of lean mass, the 2025 advisory estimates about 20% of the weight lost was muscle, and modeling suggests 10% to 15% in women and 20% to 25% in men without strength training [1].

Lean body mass includes muscle and other non-fat tissue. The advisory lists older age, perimenopause or menopause, lower testosterone, inactivity and a lack of strength training as factors that raise the risk of muscle loss, and says low protein intake from reduced appetite may add to it [1].

In a claims study of 461,382 adults starting GLP-1 medications between 2017 and 2021 (most had type 2 diabetes), muscle loss was diagnosed in 3.0% within 12 months, counting only cases that were recorded as diagnoses [3].

Is protein enough to keep muscle on a GLP-1?

Protein alone is likely not enough to keep muscle on a GLP-1. The 2025 advisory says more protein without structured strength training probably won't preserve muscle, and recommends strength training at least three times a week plus at least 150 minutes of moderate aerobic exercise weekly, adjusted to each person's fitness and physical ability [1].

Aerobic exercise alone has a smaller effect on keeping lean mass during rapid weight loss. In one randomized trial the advisory cites, a year of GLP-1 treatment plus exercise preserved bone mineral density, while GLP-1 treatment alone lowered it [1].

A 2025 perspective in the International Journal of Obesity likewise recommends prioritizing high-quality protein, ideally together with resistance training [4].

Should protein be based on your current weight or your ideal weight?

The 2025 advisory says it's unclear which weight to use. For people with obesity, basing protein on actual body weight can significantly overestimate needs, and estimated fat-free mass may work best, though there is no consensus. One option it describes is 1.5 g of protein per kilogram of lean body mass, which requires a body composition measurement [1].

Can you eat too much protein on a GLP-1?

Protein intake can be too high, according to the 2025 advisory. It says prolonged intake at or above 2 g per kilogram a day should be avoided because of potential adverse health effects, and that protein beyond what muscles need can be converted to fat by the liver. It also says intake shouldn't fall below 0.4 to 0.5 g per kilogram a day [1].

If you have kidney disease or a history of kidney stones, ask your clinician before raising protein. The advisory says people with a history of kidney stones should be counseled to avoid animal-source proteins, high-oxalate foods and highly processed foods [1].

How do you get enough protein when you're not hungry?

Eat protein-rich foods first at each meal and favor lower-volume, nutrient-dense options. The 2025 advisory suggests fish, eggs, Greek yogurt, cottage cheese, nuts, seeds and nut butters, along with beans, lentils, dairy and lean poultry, and notes that some people use high-protein shakes or bars to reach their targets. It suggests keeping red and processed meats moderate [1].

When appetite is low, small, regular meals can help, and smoothies, protein drinks, cottage cheese and soups are often easier to eat than heavier foods such as red meat, cold cuts or hard cheese. Setting a reminder to eat can help too [1].

How can you tell if you're losing muscle on a GLP-1?

Body composition tests can track muscle mass during treatment. The 2025 advisory describes bioelectrical impedance as quick and low cost, and DXA scans as the gold standard but costlier and done less often. Because those tests measure muscle mass rather than strength, simple checks such as sit-to-stand or stair-climb tests can help track function, especially in older adults [1].

Where Understory fits

Understory Nutrition sells Protocol One, a daily vitamin, mineral and digestive supplement designed to be taken alongside a GLP-1 medication. It is not a protein supplement and can't replace protein-rich food or strength training. We wrote this page because getting enough protein can be hard on these medications, whether or not you use our product.

See what Protocol One does and doesn't cover

What this evidence can't tell you

  • The protein targets come from expert guidance. A 2025 perspective notes there are no prospective studies yet on the best protein amount during GLP-1 treatment [4], and the advisory says there is no consensus on how to set targets [1].
  • The muscle figures come from one trial's body composition results and from modeling [1].
  • The food-record study had 69 participants and was funded by GNC, a supplement retailer [2].
  • The claims study counts only diagnoses that were recorded, and most participants had type 2 diabetes [3].

Sources

  1. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025;33(8):1475-1503. doi:10.1002/oby.24336 Full text. Expert advisory published in four journals; this page cites the Obesity version. A 2026 correction changed one sentence not used here.
  2. Johnson B, Milstead M, Thomas O, et al. Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study. Frontiers in Nutrition. 2025;12:1566498. doi:10.3389/fnut.2025.1566498 Full text. Three-day food records from 69 adults using a GLP-1 medication. Funded by GNC Holdings; all authors are GNC employees.
  3. Butsch WS, Sulo S, Chang AT, et al. Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study. Obesity Pillars. 2025;15:100186. doi:10.1016/j.obpill.2025.100186 Full text. Insurance claims from 461,382 adults newly prescribed a GLP-1 medication, 2017 to 2021; 80.5% had type 2 diabetes. Funded by Abbott.
  4. Spreckley M, Ruggiero CF, Brown A. Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy assisted weight loss: lessons from bariatric surgery. International Journal of Obesity. 2026;50:265-267. Published online November 15, 2025. doi:10.1038/s41366-025-01952-w. Expert perspective, not a trial or guideline. One author reports honoraria from Novo Nordisk and Eli Lilly.

These statements have not been evaluated by the Food and Drug Administration. Understory Nutrition products are not intended to diagnose, treat, cure, or prevent any disease. This page is general information, not medical advice. Talk with your prescriber before changing your diet or exercise, especially if you have kidney disease or another medical condition.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease, and are not a substitute for medical advice. Talk to your healthcare provider before starting any new supplement, especially alongside a prescription medication. Understory Nutrition products are intended to be used alongside, not in place of, GLP‑1 receptor agonist medication.

© 2026 Understory Nutrition. All rights reserved.